Prostate brachytherapy followed by secondary urethral adenocarcinoma: A case report
{{output}}
Prostate brachytherapy carries a risk of secondary malignancies, with data regarding secondary urethral malignancies being particularly sparse. We report a case of secondary urethral adenocarcinoma presenting 14 years after low-dose-rate (LDR) brachytherapy. A... ...